Fluorouracil implantable microspheres

Drug Profile

Fluorouracil implantable microspheres

Latest Information Update: 07 Oct 2004

Price : $50

At a glance

  • Originator Ethypharm
  • Class Antineoplastics; Pyrimidinones; Small molecules
  • Mechanism of Action Thymidylate synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Glioblastoma

Highest Development Phases

  • Discontinued Glioblastoma

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 07 Oct 2004 Discontinued - Phase-III for Glioblastoma in European Union (Intratumoural)
  • 04 Mar 2004 Phase-III clinical trials in Glioblastoma in European Union (Intratumoural)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top